Warning: The NCBI web site requires JavaScript to function. more...
Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future.
Twum-Danso NA.
Filaria J. 2003 Oct 24;2 Suppl 1:S7.
Related citations
Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases.
Filaria J. 2003 Oct 24;2 Suppl 1:S3.
Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.
Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas.
Filaria J. 2003 Oct 24;2 Suppl 1:S2.
Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.
Twum-Danso NA, Meredith SE.
Trop Med Int Health. 2003 Sep;8(9):820-31.
Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
Boussinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, Chippaux JP.
Am J Trop Med Hyg. 1998 Apr;58(4):461-9.
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux JP, Boussinesq M.
Lancet. 1997 Jul 5;350(9070):18-22.
[Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M, Gardon-Wendel N, Ranque S, Ndong W, Boussinesq M, Gardon J, Schneider D, Chippaux JP.
Bull Soc Pathol Exot. 1995;88(3):105-12. French.
Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.
Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P.
Filaria J. 2005 Apr 7;4(1):2.
[Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose].
Kamgno J, Gardon J, Boussinesq M.
Med Trop (Mars). 2000;60(3):275-7. French.
Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
Pion SD, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M.
Parasitology. 2006 Jul;133(Pt 1):101-9.
Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.
Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux JP.
Filaria J. 2003 Oct 24;2 Suppl 1:S4.
Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event.
Bourguinat C, Kamgno J, Boussinesq M, Mackenzie CD, Prichard RK, Geary TG.
Am J Trop Med Hyg. 2010 Jul;83(1):28-32.
Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
Pion DS, Gardon J, Kamgno J, Gardon-Wendel N, Chippaux JP, Boussinesq M.
Parasitology. 2004 Nov;129(Pt 5):613-26.
Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
Esum M, Wanji S, Tendongfor N, Enyong P.
Trans R Soc Trop Med Hyg. 2001 Nov-Dec;95(6):673-6.
Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp.
Kamgno J, Boussinesq M, Labrousse F, Nkegoum B, Thylefors BI, Mackenzie CD.
Am J Trop Med Hyg. 2008 Apr;78(4):546-51.
Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?
Pion SD, Clarke P, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M.
Parasitology. 2006 Jun;132(Pt 6):843-54. Epub 2006 Feb 10.
A Framework for Decision-Making for Mass Distribution of Mectizan(R) in Areas Endemic for Loa loa.
Addiss DG, Rheingans R, Twum-Danso NA, Richards FO.
Filaria J. 2003 Oct 24;2 Suppl 1:S9.
Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events.
Kamgno J, Pion SD, Mackenzie CD, Thylefors B, Boussinesq M.
Am J Trop Med Hyg. 2009 Dec;81(6):1056-61.
Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Kamgno J, Pion SD, Tejiokem MC, Twum-Danso NA, Thylefors B, Boussinesq M.
Trans R Soc Trop Med Hyg. 2007 Aug;101(8):777-85. Epub 2007 May 24.
Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary study.
Higazi TB, Klion AD, Boussinesq M, Unnasch TR.
Filaria J. 2004 Jun 29;3(1):4.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on